Skip to main content
. Author manuscript; available in PMC: 2023 Jun 10.
Published in final edited form as: Clin Genitourin Cancer. 2022 Jun 30;20(6):515–523. doi: 10.1016/j.clgc.2022.06.016

Table 3.

Genomic Characteristics of Cohort.

Genomic Characteristic N (%N), N = 151 total
Underwent somatic profiling 151 (100%)
  Tissue NGS only 68 (45%)
  Circulating tumor DNA (ctDNA) only 38 (25%)
  Both Tissue NGS/ctDNA 45 (30%)
Underwent germline profiling 91 (60.3%)
HRR alterations detected 37 (24.5%)
  Somatic Alteration Only 27 (73%)
  Germline Alteration Only 8 (22%)
  Somatic/Germline Co-Alteration 2 (5%)
  Single HRR alteration detected 32 (86.5%)
  Compound HRR alterations detected 5 (13.5%)